Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01527942 · ClinicalTrials.gov registry record · NA
Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients
A NA study, sponsored by Trinity Health Of New England.
- Terminated
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT01527942 is a NA study that was terminated before completion, run by Trinity Health Of New England. The registered enrollment target is 34 participants.
The verdict
NCT01527942, a NA study, was terminated before completion, sponsored by Trinity Health Of New England.
- TERMINATED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Bariatric patients usually require the use of either intravenous or oral opioid medications. The use of opioids, however, is often associated with side-effects such as nausea, sedation pruritus, urinary retention and respiratory depression with often delay patient discharge. This study makes use of intravenous acetaminophen , a non-opioid analgesic preoperatively to determine if this will decrease the use of opioids post-operatively for pain management in morbidly obese patients undergoing laparoscopic bariatric surgery.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01527942
The ClinicalTrials.gov registry entry for NCT01527942 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trinity Health Of New England, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01527942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01527942 about?
NCT01527942 is a clinical study titled "Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients". Bariatric patients usually require the use of either intravenous or oral opioid medications. The use of opioids, however, is often associated with side-effects such as nausea, sedation pruritus, urinary retention and respiratory depression with often delay patient discharge. This study makes use of ...
What is the current status of trial NCT01527942?
This trial is currently terminated. It is a NA study. The enrollment target is 34 participants. The study started on 2012-03. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01527942?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT01527942?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.